Sanapac GMP deficiencies
This article was originally published in The Tan Sheet
Executive Summary
Outlined by FDA in an April 19 letter to Dallas, Penn.-based Sanapac Co., problems include failure to package iron supplements in solid oral dosage form in unit-dose packaging. The company, which distributes products primarily on the East Coast, is recalling its products and adding child-proof caps to containers. Sanapac's iron-containing products include Sanapac Rooster brand pills, Rooster Kings, Super Kings Inner Man, Sanapac Inner Man Gold and Super Queens Inner Woman. FDA inspected the company's repackaging and distribution facility on Feb. 11. The agency also notes the company's dietary supplements are misbranded because their labeling bears National Drug Code listing numbers
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning